Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 7/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22693798 | 0.88 | ALDH1A1 (0.45) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL3831348 | 0.86 | ALDH1A1 (0.42) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL3832638 | 0.81 | ALDH1A1 (0.45) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL20194389 | 0.76 | ALDH1A1 (0.50) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL3831548 | 0.76 | ALDH1A1 (0.48) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL7616135 | 0.75 | GPR84 (0.42) | ALDH1A1MEN1KMT2AFAAHCNR1 | |
| SCHEMBL8895646 | 0.74 | ALDH1A1 (0.58) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL15708344 | 0.74 | PTPN1 (0.51) | ALDH1A1FAAHCNR1PTPN1 | |
| SCHEMBL10533934 | 0.73 | ALDH1A1 (0.44) | ALDH1A1MEN1USP2MAPTKMT2A | |
| SCHEMBL607172 | 0.73 | TP53 (0.53) | ALDH1A1MEN1USP2MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218117-A1 | POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES | Visolis, Inc. | 2024-07-04 | — | — | US | disclosed |
| US-20200369827-A1 | POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES | Visolis, Inc. | 2020-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369827-A1 | POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES | COASY, FASN, GGPS1 | ALDH1A1 968/4885MEN1 677/4885USP2 1832/4885 |
| US-20240218117-A1 | POLYMERS PREPARED FROM MEVALONOLACTONE AND DERIVATIVES | COASY, FASN, GGPS1 | ALDH1A1 968/4885MEN1 677/4885USP2 1832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.